CWM LLC grew its holdings in GRAIL, Inc. (NASDAQ:GRAL - Free Report) by 248.3% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 22,715 shares of the company's stock after acquiring an additional 16,193 shares during the quarter. CWM LLC owned 0.06% of GRAIL worth $580,000 as of its most recent SEC filing.
A number of other institutional investors also recently modified their holdings of the business. State of Tennessee Department of Treasury bought a new stake in GRAIL during the fourth quarter worth about $28,000. Caldwell Sutter Capital Inc. bought a new position in shares of GRAIL in the first quarter worth about $28,000. Sterling Capital Management LLC bought a new position in shares of GRAIL in the fourth quarter worth about $29,000. KBC Group NV lifted its holdings in shares of GRAIL by 187.7% in the first quarter. KBC Group NV now owns 1,430 shares of the company's stock worth $37,000 after acquiring an additional 933 shares during the last quarter. Finally, S.A. Mason LLC lifted its holdings in shares of GRAIL by 50.1% in the first quarter. S.A. Mason LLC now owns 1,499 shares of the company's stock worth $38,000 after acquiring an additional 500 shares during the last quarter.
Insider Activity
In other news, CEO Robert P. Ragusa sold 94,035 shares of the firm's stock in a transaction that occurred on Friday, May 2nd. The shares were sold at an average price of $33.93, for a total transaction of $3,190,607.55. Following the completion of the sale, the chief executive officer owned 734,627 shares of the company's stock, valued at $24,925,894.11. This trade represents a 11.35% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, President Joshua J. Ofman sold 9,692 shares of the firm's stock in a transaction that occurred on Monday, June 30th. The stock was sold at an average price of $52.00, for a total transaction of $503,984.00. Following the sale, the president directly owned 492,076 shares of the company's stock, valued at approximately $25,587,952. This trade represents a 1.93% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 540,890 shares of company stock worth $23,868,412. 1.85% of the stock is owned by company insiders.
GRAIL Stock Up 1.4%
Shares of GRAL stock traded up $0.57 on Friday, reaching $40.29. The company had a trading volume of 551,688 shares, compared to its average volume of 1,320,343. The stock has a market capitalization of $1.45 billion and a PE ratio of -0.66. GRAIL, Inc. has a one year low of $12.33 and a one year high of $63.99. The business's 50-day moving average is $41.84 and its 200 day moving average is $34.88.
GRAIL (NASDAQ:GRAL - Get Free Report) last released its earnings results on Tuesday, May 13th. The company reported ($3.10) earnings per share for the quarter, beating analysts' consensus estimates of ($4.03) by $0.93. The business had revenue of $31.84 million during the quarter, compared to the consensus estimate of $35.80 million. GRAIL had a negative net margin of 1,464.53% and a negative return on equity of 17.99%. On average, sell-side analysts forecast that GRAIL, Inc. will post -15.15 earnings per share for the current fiscal year.
Analysts Set New Price Targets
Separately, Canaccord Genuity Group increased their target price on shares of GRAIL from $32.00 to $43.00 and gave the stock a "buy" rating in a report on Wednesday, May 14th.
Get Our Latest Report on GRAL
About GRAIL
(
Free Report)
GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.
Read More

Before you consider GRAIL, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GRAIL wasn't on the list.
While GRAIL currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.